On 23-25 of October 2015, more than 150 experts from all over the world gathered at an international congress sponsored by BD in Rome, Italy, Forum for Injection Technique and Therapy Expert Recommendations (FITTER), to discuss injection technique, infusion and safety, with the objective of improving diabetes management for millions of people across the globe.
Over 14,000 virtual delegates joined many of the world’s leading experts of FITTER to review research findings, including the results of a recent global injection technique questionnaire (ITQ), for the development of new international recommendations on injection technique and safety, expected Spring 2016. A two-day programme of presentations and breakout sessions covered a wide range of related topics, including education and training, infusion and safety.
Already a major health concern, the prevalence of diabetes is increasing on a world-wide scale. The International Diabetes Federation forecasts that 592 million people worldwide will have diabetes by 2035. The number of people with Type 2 diabetes is on the rise in every country, with earlier diagnosis and longer life spans meaning that there is an increasing likelihood that they will need to use injectable therapies to control their condition. Against this background, the congress focused on the wealth of research demonstrating that education on injection and infusion technique is as critical to diabetes management and care as insulin, diet and activity. [i][ii] As well as reviewing the clinical evidence and literature on the topic, the 13 members of the FITTER Scientific Advisory Board*, in discussion with delegates, considered the results of the global ITQ survey. One of the largest surveys ever completed, ITQ included input from more than 13,000 respondents from 42 countries, demonstrating the importance of this topic.
There is extensive research to show the positive impact that correct injection technique can have on the health outcomes of people with diabetes; a recent study by Grassi et al is just one example that showed injection technique education not only improved blood glucose control in people with diabetes, but also provided greater satisfaction with therapy and lowered the daily consumption of insulin after only three months - a relatively short period of time.i
“The key is education and FITTER’s mission is to reach the influencers, educators and health care workers who will support and disseminate the new recommendations in their daily practice,” saysKenneth Strauss, Global Medical Director, BD Medical – Diabetes Care. “This has been a hugely successful event, and a clear expression of the level of interest that exists across the world on the vital role that injection technique plays in diabetes care. The new recommendations will be available in Spring 2016 and they will be made widely available for anyone involved in diabetes care across the world.”
[ii] M.Morimoto, H.Fukumoto and E. Kawabata, Family Education program for the Hospitalized diabetic patient,within 16th International Diabetes Federation Congress. Helsinki, Finland, 20-25 July 1997. Abstracts., Diabetologia.1997 Jun;40 Suppl 1:A1-721
*FITTER Scientific Advisory Board: Dr. Bruce W. Bode, MD Diabetes Specialist at Atlanta Diabetes Associates, Georgia, USA, and Professor of Medicine at Emory University; Dr. Anders Frid, Senior Consultant at the Clinic of Endocrinology, University Hospital SUS, Malmӧ, Sweden; Dr. Giorgio Grassi, Senior Physician , Division of Endocrinology at the Ospedaliero - Universitaria San Giovanni Battista di Torino, Italy; Professor Serge Halimi, Head of Department of Endocrinology Diabetology Nutrition, University Hospital, Grenoble, France; Debbie Hicks, Nurse Consultant - Diabetes, Barnet, Enfield and Haringey Mental Health Trust, chair of FIT (Forum of Injection Technique) UK and President of FIT International; Dr. Irl Hirsch, Professor of Medicine, University of Washington, USA; Dr. Larry Hirsch, Vice President, Global Medical Affairs, BD Medical, Diabetes Care; Dr. Sanjay Kalra, DM (AIIMS), Consultant Endocrinologist, Bharti Hospital, Karnal, Haryana, India;Professor Linong Ji, Chief Physician and Head of Endocrinology Department, Peking University People’s Hospital, China; Gillian Kreugel, Nurse Consultant – Diabetes, University Medical Centre, Groningen, The Netherlands; Mike Smith, European Clinical Marketing Manager – BD Medical – Diabetes Care, Diabetes Specialist Nurse; Dr. Kenneth Strauss, Global Medical Director, BD Diabetes Care Endocrinologist and Director of Safety in Medicine, European Medical Association; Dr. Regine Wellhӧner, Specialist in Internal Medicine with Diabetology, Endocrinology and Nephrology and former Diabetes Department Red Cross Hospital, Kassel, Germany.